课题基金 / 基金详情

Image-Guided Surgery of Endocrine Glands and Their Tumors using Near-Infrared Flu

Image-Guided Surgery of Endocrine Glands and Their Tumors using Near-Infrared Flu
使用近红外流感图像引导内分泌腺及其肿瘤手术
批准号:
7986899
负责人:
Hak Soo Choi
金额:
$51.39万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-08-01 至 2014-04-30

项目摘要

项目成果

Hak Soo Choi的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):内分泌肿瘤,如胰岛素瘤,是罕见的,但出了名的难以手术治疗,因为它们体积小,使用白光对比度差。内分泌肿瘤,如卵巢癌,是常见的,但同样难以手术治疗,提高存活率依赖于完全的细胞减少。同样,正常的内分泌组织,如甲状腺和肾上腺,由于粘连和覆盖的筋膜,在手术中往往很难定位。我们的假设是,在一次手术前静脉注射后,针对内分泌腺及其肿瘤的近红外(NIR)荧光团将为外科医生提供灵敏、特异和实时的图像指导。当与适当的术中成像系统配合使用时,700到900 nm的近红外荧光灯可以为外科医生提供正常和病变组织的实时定位,而不会改变手术视野的外观。作为之前资助的生物工程研究伙伴关系(BRP)赠款的一部分,我们开发了FLARE(荧光辅助切除和探查)图像引导手术系统。FLARE通过两个独立的近红外荧光通道(700 nm和800 nm发射)同时提供手术解剖的实时成像(即彩色视频)。一个近红外通道通常预留给要切除的组织(例如,肿瘤),而另一个预留给需要避免的组织(例如,神经、血管、正常腺体等)。Flare已经被翻译到临床上,在那里它被用于乳腺癌前哨淋巴结(SLN)标测、肺癌SLN标测和整形手术。切除内分泌腺肿瘤(如胰岛素瘤和卵巢癌)和避免正常的内分泌组织(如甲状腺和肾上腺)是一个重要的未得到满足的临床需求,没有可用的造影剂。我们与佐治亚州立大学的希莱姆/斯特雷科夫斯基/帕托奈实验室合作,开发了适用于内分泌成像的新型近红外荧光团(内分泌特异性近红外荧光团;ESNF),该实验室是荧光团化学领域公认的领导者。ESNF与自然产生的激素和药物在结构和化学上具有相似之处,在小鼠、大鼠和猪体内单次静脉注射后,为图像引导手术提供了高对比度。这笔赠款的具体目标集中在合成三种新的ESNF化学类别,从分析性生产扩大到制备性生产,以及优化其光学和化学性质。这些目标的完成将为未来图像引导手术中ESNF的临床测试奠定基础。 公共卫生相关性:不可见的近红外荧光灯可以在手术中提供敏感和特定的指导,但前提是有最佳的造影剂可用。内分泌组织及其肿瘤在手术中特别难发现,但目前尚不存在内分泌特异性近红外荧光造影剂。我们已经发现某些花菁和碱性苯胺近红外荧光团对内分泌的特异性吸收,并在这一赠款申请中描述了这些药物的优化以及用于图像引导手术的三个新的近红外荧光团家族的开发。
英文摘要
DESCRIPTION (provided by applicant): Endocrine tumors, such as insulinoma, are rare but notoriously difficult to treat surgically due to their small size and poor contrast using white light. Endocrine tumors, such as ovarian cancer, are common but equally difficult to treat surgically, with improved survival dependent on complete cytoreduction. Similarly, normal endocrine tissues, such as the thyroid gland and adrenal gland, can often be difficult to locate during surgery due to adhesions and overlying fascia. Our hypothesis is that near-infrared (NIR) fluorophores targeted to endocrine glands and their tumors will provide surgeons with sensitive, specific, and real-time image- guidance after a single, pre-operative, intravenous injection. When used with an appropriate intraoperative imaging system, NIR fluorescent light from 700 to 900 nm can provide surgeons with real-time localization of normal and diseased tissue, without changing the look of the surgical field. As part of a previously funded Bioengineering Research Partnership (BRP) grant, we have developed the FLARE" (Fluorescence-Assisted Resection and Exploration) image-guided surgery system. FLARE provides real-time imaging of surgical anatomy (i.e., color video) simultaneously with two independent channels of NIR fluorescent light (700 nm and 800 nm emission). One NIR channel is typically reserved for the tissue to be resected (e.g., tumor) while the other is reserved for tissue that needs to be avoided (e.g., nerves, blood vessels, normal glands, etc.). FLARE has already been translated to the clinic where it is being used in breast cancer sentinel lymph node (SLN) mapping, lung cancer SLN mapping, and plastic surgery. The resection of endocrine gland tumors (e.g., insulinoma and ovarian cancer) and the avoidance of normal endocrine tissue (e.g., thyroid and adrenal glands) represent a significant unmet clinical need, with no available contrast agents. In collaboration with the Henary/Strekowski/Patonay laboratory at Georgia State University, recognized leaders in the field of fluorophore chemistry, we have developed novel NIR fluorophores tailored to endocrine imaging (endocrine-specific NIR fluorophores; ESNFs). Sharing structural and chemical similarities with naturally occurring hormones and drugs, ESNFs provide high contrast for image-guided surgery after a single intravenous injection into mice, rats, and pigs. The specific aims of this grant are focused on the synthesis of three new chemical classes of ESNFs, scale-up from analytical to preparative production, and optimization of their optical and chemical properties. Completion of these aims will lay the foundation for future clinical testing of ESNFs during image-guided surgery. PUBLIC HEALTH RELEVANCE: Invisible near-infrared fluorescent light can provide sensitive and specific guidance during surgery, but only if optimal contrast agents are available. Endocrine tissues and their tumors are particularly difficult to find during surgery, yet no endocrine-specific near-infrared fluorescent contrast agents presently exist. We have discovered endocrine-specific uptake by certain cyanine and basic aniline near- infrared fluorophores, and in this grant application, describe optimization of these agents and the development of three new families of near-infrared fluorophores for image-guided surgery.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Long-Acting, Short-Residing Nanochelators for Iron Overload Therapy
  • 批准号:
    10585319
  • 项目类别:
  • 资助金额:
    $73.42万
  • 财政年份:
    2023
  • 负责人:
    Hak Soo Choi
  • 依托单位:
Nanochelation Therapies for Iron Overload Disorders
Nanochelation Therapies for Iron Overload Disorders
Image-Guided Drug Delivery and Treatment for GIST
  • 批准号:
    9792375
  • 项目类别:
  • 资助金额:
    $17.77万
  • 财政年份:
    2018
  • 负责人:
    Hak Soo Choi
  • 依托单位:
海外基金